Breaking News
FONT-SIZE Plus   Neg
Share SHARE

Novo Nordisk Announces Share Repurchase Program

RELATED NEWS
Trade NVO now with 

Novo Nordisk A/S (NVO: Quote), the world's largest insulin maker, said Monday that on January 31 it initiated a share repurchase program in accordance with the provisions of the Safe Harbour rules.

Under the programme Novo Nordisk will repurchase up to DKK 3.0 billion of B shares the period from January 31 to April 29.

Transactions related to Novo Nordisk's incentive programs have resulted in a net sale by Novo Nordisk of 783,652 B shares in the period from January 31 to February 8. The shares in those transactions were not part of the Safe Harbour repurchase program.

Novo Nordisk expects to repurchase up to DKK 14.0 billion of B shares f during a 12 month period beginning January 31, 2013. As of February 8, the company said it has repurchased a total of 334,310 B shares for an aggregate value of about DKK 352.5 milion.

The total amount of shares in the company is 560 million including treasury shares.

Click here to receive FREE breaking news email alerts for Novo Nordisk A/S and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Editors Pick
This apparel maker has doubled its earnings per share in just two years and increased its annual earnings forecast from time to time, despite a challenging consumer spending environment. Contributions from acquisitions, efficiency gains from self-owned global supply chain and benefits from 'Innovate-to-Elevate' strategy continue to boost the company's results. Here is a quick summary of the earnings reported after the bell on Nov 20. We have 20+ stocks listed here. The good news is you can skip this step. There is a next move that can make your life a lot easier. Our research team has already done the groundwork for you. All these stocks listed... Design software maker Autodesk, Inc. said Thursday after the markets closed that its third quarter profit fell 81% from last year, as higher costs and expenses more than offset an 11% increase in revenue. However, the company's quarterly earnings per share, excluding items, came in above analysts' expectations as did its quarterly revenue.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.